CAI CIK: 2019410

Caris Life Sciences, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25
(positive)
Change from FY23 to FY25
millions USD
FY23:
89.3
FY24:
179
FY25:
539
(positive)
Change from FY23 to FY25
millions USD
FY23:
−320
FY24:
−257
FY25:
45.1
(positive)
Change from FY23 to FY25
millions USD
FY23:
−261
FY24:
−201
FY25:
83.6
(positive)
Change from FY23 to FY25
millions USD
FY23:
−341
FY24:
−282
FY25:
−68.1
(positive)
Change from FY23 to FY25
millions USD
FY23:
−341
FY24:
−282
FY25:
−68.1

All amounts in millions USD Data sources:SEC EDGARTwelve Data